Provectus Biopharmaceuticals Inc (OTCQB:PVCT)

0.08
Delayed Data
As of Feb 23
 -0.0005 / -0.62%
Today’s Change
0.02
Today|||52-Week Range
0.09
-2.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization677.5K679.7K684.3K684.2K
 
 
 
 
 
 
Operating ExpensesGross Income-677.5K-679.7K-684.3K-684.2K
 
 
 
 
 
General Expenses12.4M16.1M24.0M23.8M
 
 
 
 
 
Research And Development3.6M5.1M10.7M7.9M
 
 
 
 
 
Total Operating Expenses13.0M16.8M24.7M24.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-16.8M-24.7M-24.5M
 
 
 
 
 
Extraordinary Credit0.006.6M146.6K518.9K
 
 
 
 
Extraordinary Charge-14.7M0.000.00-436.2K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.7M-10.2M-24.5M-24.4M
 
 
 
 
 
Preferred Dividend-1.2M0.000.00-4.4M
 
 
 
Net Income-27.7M-10.2M-24.5M-24.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS132.0M175.8M195.7M233.8M
 
 
 
 
 
Shares To Calculate EPS Diluted132.0M175.8M195.7M233.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.06-$0.13-$0.12
 
 
 
 
 
EPS Diluted-$0.22-$0.06-$0.13-$0.12